How Can New Myeloma Treatments Play a Role When Maintenance Therapy Becomes Ineffective?

How Can New Myeloma Treatments Play a Role When Maintenance Therapy Becomes Ineffective?

P2Professional

4 years
327 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Myeloma expert Dr. Robert Orlowski answers more Ask the Expert questions, this one from Susan: What effect will newly approved drugs, such as daratumamab and ixazomib have on a patient when Revlimid maintenance is no longer effective? Dr. Orlowski gives a detailed answer, including a newer drug, isatuximab, that he says, looks like an active and exciting drug.

Get email alerts | http://www.patientpower.info/alerts

Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo
Up Next Autoplay